I just read the news piece on over supply of rats yesterday but I think they should have had a better understanding of this dynamic before hand. This will wash through and hopefully the new sales will start to show. Consumer health was pleasing again. If you take out 2022 which was an exceptional year general growth is still heading in the right direction. Cash is critical and they need those Rhino Swab revenues to flow or its going to get tight.
So, disappointed in BTNX sales and subsequent rev. loss but happy with over all progress, I don't think RNO can help the stupidity of Governments when it comes to over ordering but hope that they are using the lag to promote a better accurate and comfortable standardized swab test.
I'll continue to hold and hope that March provides some positive news flow.
RNO Price at posting:
11.0¢ Sentiment: Hold Disclosure: Held
